Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Consequently, its market share is closer to 10%, compared with the 3% that we reported.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

APRIL 1, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Click here to see the original post from December 2023. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.

Pharmacy 86

Pharmacy Hospitals Pharmaceuticals Drugs 86

Drug Channels

DECEMBER 5, 2023

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Tomorrow on Drug Channels , I’ll delve into the pros and cons of this new approach. to 1:30 p.m.

Pharmacy 83

Pharmacy Drugs Hospitals Pharmaceuticals 83

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.

Pharmacy 75

Pharmacy Drugs Marketing 75

Drug Channels

JUNE 23, 2023

Click here to see the original post from January 2023. Now that 2023 is underway, let’s review employer-sponsored coverage for prescription drugs and speculate on what’s ahead. Below I examine the latest data on pharmacy benefits: cost sharing tier structures, copayment vs. coinsurance, and out-of-pocket obligations.

Pharmacy 77

Pharmacy Drugs 77

Drug Channels

OCTOBER 22, 2024

Reality has again failed to support the spin surrounding the 340B Drug Pricing Program. For 2023, discounted purchases under the 340B program reached a record $66.3 340B purchases are now almost 40% larger than Medicaid’s prescription drug purchases. Hospitals again accounted for 87% of 340B purchases for 2023.

Pharmacy 81

Pharmacy Hospitals Drugs 81

Drug Channels

NOVEMBER 1, 2022

Open enrollment is under way for the 2023 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as an established component of Part D benefit design. d/b/a Drug Channels Institute.

Pharmacy 85

Pharmacy Independent Pharmacies Drugs 85

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. Click here to see the original post from April 2024. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Production Drugs 52

Drug Channels

APRIL 12, 2023

In Drug Channels Institute’s list of the top 15 pharmacies of 2022 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Specialty Pharmacies 95

Specialty Pharmacies Pharmacy Independent Pharmacies Hospitals 95

Drug Channels

FEBRUARY 14, 2023

This Valentine's Day, what could be more romantic than a deep dive into the relationships between manufacturers of specialty drugs and the pharmacies they choose for their limited and exclusive specialty pharmacy networks. As you’ll see, a typical network contains only five specialty pharmacies.

Pharmacy 73

Pharmacy Specialty Pharmacies Drugs Production 73

Drug Channels

APRIL 24, 2024

Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In those exclusive networks, independent and smaller specialty pharmacies are the big winners.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Production Drugs 52

Drug Channels

NOVEMBER 15, 2023

In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans.

Pharmacy 89

Pharmacy Drugs Marketing 89

Drug Channels

JULY 11, 2023

Looks like pharmacy and PBM profiteering within the 340B Drug Pricing Program will never go out of style. Drug Channels Institute’s (DCI) latest analysis reveals that more than 33,000 pharmacy locations —more than half of the entire U.S. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmacy 54

Pharmacy Marketing Hospitals Drugs 54

Drug Channels

NOVEMBER 7, 2023

As many of you know, hospitals and health systems have emerged as significant participants in the specialty pharmacy industry. A new American Society of Hospital Pharmacists (ASHP) survey provides fresh insights into these specialty pharmacies. Below, I review key findings on the economics and operations of these specialty pharmacies.

Specialty Pharmacies 70

Specialty Pharmacies Pharmacy Hospitals International 70

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before April 3, 2023. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 87

Pharmacy Specialty Pharmacies Marketing Drugs 87

Drug Channels

JUNE 17, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Three is still the magic number for pharmacy benefit managers (PBMs). Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

SEPTEMBER 27, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. I recommend that you follow me on LinkedIn, because the quality of comments and engagement is much higher than they are on Twitter. I’m not posting to Threads yet.)

Pharmacy 76

Pharmacy Specialty Pharmacies Drugs 76

Drug Channels

APRIL 4, 2024

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

FDA Law Blog: Biosimilars

MAY 30, 2024

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. In United Therapeutics Corporation v.

Pharmacy 57

Pharmacy Pharmaceuticals Drugs Government 57

Drug Channels

MARCH 7, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m. to 1:30 p.m.

Pharmacy 83

Pharmacy Drugs Marketing 83

Drug Channels

JANUARY 24, 2023

Now that 2023 is underway, let’s review employer-sponsored coverage for prescription drugs and speculate on what’s ahead. Below I examine the latest data on pharmacy benefits: cost sharing tier structures, copayment vs. coinsurance, and out-of-pocket obligations. d/b/a Drug Channels Institute. Beneficiary beware!

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

APRIL 2, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For more on acquisition cost reimbursement for pharmacies, see Sections 8.4. Pharmacies and Pharmacy Benefit Managers. and 12.3.4. of our new 2024 Economic Report on U.S.

Pharmacy 64

Pharmacy Drugs 64

Drug Channels

MAY 23, 2023

Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. In the meantime, tune in for more PBM-bashing at today's House hearing: The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part I: Self-Interest or Health Care?

Pharmacy 93

Pharmacy Marketing Drugs 93

FDA Law Blog: Biosimilars

MARCH 24, 2024

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103).

Pharmacy 57

Pharmacy Regulations Compliance Drugs 57

Drug Channels

DECEMBER 6, 2022

In Preferred Pharmacy Networks in 2023’s Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More , I highlighted how those networks have taken over the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans.

Pharmacy 94

Pharmacy Drugs Marketing 94

Drug Channels

NOVEMBER 9, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2023. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. d/b/a Drug Channels Institute. to 1:30 p.m.

Specialty Pharmacies 80

Specialty Pharmacies Pharmacy Biosimilars Drugs 80

Drug Channels

MARCH 28, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Click here to see the original post and comments from January 2023. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Biosimilars 96

Biosimilars Pharmacy Drugs Production 96

Drug Channels

DECEMBER 6, 2023

Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? I commend CVS Health for attempting to address key economic challenges facing the retail pharmacy industry and for tackling the hidden complexities of PBM pricing models. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmacy 68

Pharmacy Drugs 68

Drug Channels

DECEMBER 13, 2023

This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. Click here to see the original post from September 2023. Time for our annual update on the channels for provider-administered drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Specialty Pharmacies 81

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 81

FDA Law Blog: Biosimilars

MARCH 29, 2023

Richardson — Early on March 29, 2023, FDA announced the landmark approval of Narcan (naloxone hydrochloride) Nasal Spray for use as a nonprescription opioid overdose reversal agent. When OTC NNS will become commercially available is ultimately determined by the sponsor of the drug—Emergent BioSolutions. launch would be in early 2024.

Pharmacy 104

Pharmacy FDA FDA Approval Production 104

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. The rise of discount card pricing within pharmacy benefit plans is a positive development. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmacy 78

Pharmacy Drugs Marketing 78

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. However, I suspect few people understand that placing discount cards within the pharmacy benefit enables a PBM to monetize a new fee stream from the card vendor. d/b/a Drug Channels Institute. Links below. to 1:30 p.m. to 1:30 p.m.

Pharmacy 87

Pharmacy Drugs Marketing 87

Drug Channels

AUGUST 15, 2023

The likelihood of major national legislation over the pharmacy benefit management (PBM) industry has never been greater. Today, I review some surprising new data on a crucial aspect of the drug channel: how employer-sponsored health plans access the billions of dollars in manufacturer rebates that are negotiated by their PBMs.

Pharmacy 85

Pharmacy Drugs 85

Drug Channels

MARCH 29, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. One follow-up to this rerun: Kroger’s participation as a preferred pharmacy declined significantly due to its Express Scripts relationship.

Pharmacy 76

Pharmacy Drugs 76

Drug Channels

SEPTEMBER 13, 2023

Time for our annual update on the channels for provider-administered drugs. For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 74

Drug Channels

JULY 16, 2024

Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). The report’s unsubtle subtitle revealed how the agency views PBMs: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Pharmaceuticals Production Drugs 52

Drug Channels

JANUARY 17, 2023

Consolidation has brought together large, economically significant insurer/PBM/specialty pharmacy/provider organizations within U.S. drug channels. In the brief video clip below, I review these businesses and offer some thoughts on their positioning for 2023. Or register for my forthcoming 2023 video webinar series.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Drugs 97